8,430 dead, 354,177 injuries following COVID-19 experimental ‘vaccines’ reported in Europe

Share this:

EudraVigilance, a European database of suspicious drug reaction cases, has reported 8,430 deaths and 354,177 injuries following injections of four experimental Chinese Communist Party (CCP) Virus (COVID-19) shots.

In a statement about their database, said that their report covers data collected through April 24, 2021, for four experimental vaccines currently in use in Europe from Pfizer, AstraZeneca, Moderna, and Johnson & Johnson:

4,524  of the 8,430 deaths were reported following Pfizer vaccine injections, and 184,833 of the 354,177 injuries following AstraZeneca vaccine injections, according to EudraVigilance, which monitors reports of accidents and deaths related to the experimental CCP Virus vaccines.

The following is a rundown of the data through April 24:

Total reactions for the experimental mRNA vaccine Tozinameran (code BNT162b2, Comirnaty) from BioNTech/Pfizer: 4,524 deaths and 151,306 injuries

  • 11,191   Blood and lymphatic system disorders incl. 40 deaths
  • 7,372     Cardiac disorders incl. 522 deaths
  • 50           Congenital, familial and genetic disorders incl. Three deaths
  • 4,183     Ear and labyrinth disorders incl. Three deaths
  • 112        Endocrine disorders
  • 4,629     Eye disorders incl. Six deaths
  • 33,33     Gastrointestinal disorders incl. 227 deaths
  • 103,813General disorders and administration site conditions incl. 1459 deaths
  • 214        Hepatobiliary disorders incl. 16 deaths
  • 3,338     Immune system disorders incl. 20 deaths
  • 10,160   Infections and infestations incl. 527 deaths
  • 3,950     Injury, poisoning, and procedural complications incl. 89 deaths
  • 7,595     Investigations incl. 168 deaths
  • 2,564     Metabolism and nutrition disorders incl. 91 deaths
  • 53,714   Musculoskeletal and connective tissue disorders incl. 47 deaths
  • 150        Neoplasms benign, malignant, and unspecified (incl cysts and polyps) incl. Seven deaths
  • 65,745   Nervous system disorders incl. 425 deaths
  • 192        Pregnancy, puerperium, and perinatal conditions incl. Seven deaths
  • 80           Product issues
  • 6,008     Psychiatric disorders incl. 63 deaths
  • 938        Renal and urinary disorders incl. 66 deaths
  • 994        Reproductive system and breast disorders incl. One death
  • 13,954   Respiratory, thoracic, and mediastinal disorders incl. 523 deaths
  • 16,171   Skin and subcutaneous tissue disorders incl. 35 deaths
  • 438        Social circumstances incl. Six deaths
  • 124        Surgical and medical procedures incl. Eight deaths
  • 8,220     Vascular disorders incl. 165 deaths

Total reactions for the experimental mRNA vaccine mRNA-1273 (CX-024414) from Moderna: 2,283 deaths and 17,625 injuries

  • 839        Blood and lymphatic system disorders incl. 16 deaths
  • 1,278     Cardiac disorders incl. 231 deaths
  • 7             Congenital, familial, and genetic disorders incl. 2 deaths
  • 378        Ear and labyrinth disorders
  • 23           Endocrine disorders incl. One death
  • 570        Eye disorders incl. Three deaths
  • 3,857     Gastrointestinal disorders incl. 80 deaths
  • 12,513   General disorders and administration site conditions incl. 1012 deaths
  • 77           Hepatobiliary disorders incl. Three deaths
  • 476        Immune system disorders incl. Three deaths
  • 1,449     Infections and infestations incl. 118 deaths
  • 803        Injury, poisoning, and procedural complications incl. 44 deaths
  • 1,087     Investigations incl. 60 deaths
  • 515        Metabolism and nutrition disorders incl. 47 deaths
  • 5,669     Musculoskeletal and connective tissue disorders incl. 47 deaths
  • 48           Neoplasms benign, malignant, and unspecified (incl cysts and polyps) incl. Eight deaths
  • 7,489     Nervous system disorders incl. 244 deaths
  • 50           Pregnancy, puerperium, and perinatal conditions
  • 8             Product issues
  • 862        Psychiatric disorders incl. 31 deaths
  • 299        Renal and urinary disorders incl. 23 deaths
  • 106        Reproductive system and breast disorders incl. One death
  • 2,198     Respiratory, thoracic, and mediastinal disorders incl. 197 deaths
  • 2,163     Skin and subcutaneous tissue disorders incl. 19 deaths
  • 162        Social circumstances incl. Six deaths
  • 109        Surgical and medical procedures incl. 13 deaths
  • 1,166     Vascular disorders incl. 74 deaths

Total reactions for the experimental vaccine AZD1222 (CHADOX1 NCOV-19) from Oxford/AstraZeneca: 1,579 deaths and 184,833 injuries

  • 5,319     Blood and lymphatic system disorders incl. 64 deaths
  • 7,374     Cardiac disorders incl. 199 deaths
  • 76           Congenital, familial and genetic disorders incl. 2 deaths
  • 5,011     Ear and labyrinth disorders
  • 155        Endocrine disorders incl. 2 deaths
  • 7,922     Eye disorders incl. Five deaths
  • 56,473   Gastrointestinal disorders incl. 62 deaths
  • 141,042General disorders and administration site conditions incl. 495 deaths
  • 248        Hepatobiliary disorders incl. 13 deaths
  • 1,837     Immune system disorders incl. Seven deaths
  • 10,631   Infections and infestations incl. 99 deaths
  • 4,341     Injury, poisoning, and procedural complications incl. 18 deaths
  • 9,798     Investigations incl. 21 deaths
  • 6,977     Metabolism and nutrition disorders incl. 18 deaths
  • 82,522   Musculoskeletal and connective tissue disorders incl. 16 deaths
  • 144        Neoplasms benign, malignant, and unspecified (incl cysts and polyps) incl. 4 deaths
  • 111,873Nervous system disorders incl. 244 deaths
  • 108        Pregnancy, puerperium, and perinatal conditions
  • 52           Product issues
  • 9,514     Psychiatric disorders incl. 12 deaths
  • 1,745     Renal and urinary disorders incl. 11 deaths
  • 2,076     Reproductive system and breast disorders
  • 15,824   Respiratory, thoracic, and mediastinal disorders incl. 171 deaths
  • 23,168   Skin and subcutaneous tissue disorders incl. 10 deaths
  • 364        Social circumstances incl. Three deaths
  • 383        Surgical and medical procedures incl. 12 deaths
  • 8,706     Vascular disorders incl. 91 deaths

Total reactions for the experimental COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 44 deaths and 413 injuries

  • 11           Blood and lymphatic system disorders
  • 45           Cardiac disorders incl. 10 deaths
  • 1             Congenital, a familial and genetic disorder
  • 20           Ear and labyrinth disorders
  • 1             Endocrine disorder
  • 20           Eye disorders
  • 109        Gastrointestinal disorders incl. One death
  • 235        General disorders and administration site conditions incl. 14 deaths
  • 3             Hepatobiliary disorders
  • 18           Immune system disorders
  • 44           Infections and infestations incl. 2 deaths
  • 34           Injury, poisoning, and procedural complications incl. One death
  • 61           Investigations
  • 19           Metabolism and nutrition disorders incl. One death
  • 95           Musculoskeletal and connective tissue disorders incl. One death
  • 232        Nervous system disorders incl. Three deaths
  • 3             Product issues
  • 45           Psychiatric disorders
  • 11           Renal and urinary disorders
  • 5             Reproductive system and breast disorders
  • 80           Respiratory, thoracic, and mediastinal disorders incl. Three deaths
  • 50           Skin and subcutaneous tissue disorders
  • 5             Social circumstances
  • 3             Surgical and medical procedures
  • 96           Vascular disorders incl. Eight deaths

This data is provided by the European Medicines Agency (EMA), and anybody can check it using the EudraVigilance framework.

The use of AstraZeneca’s experimental CCP Virus shots has been effectively halted in Denmark and Norway.

According to a Norwegian Institute of Public Health statement, the AstraZeneca COVID-19 “vaccine” is riskier than the virus itself, particularly for young people.

Article Source: 8,430 dead, 354,177 injuries following COVID-19 experimental ‘vaccines’ reported in Europe | The BL


Share this:
Scroll to Top